O

Optomed Oyj
OMXH:OPTOMED

Watchlist Manager
Optomed Oyj
OMXH:OPTOMED
Watchlist
Price: 3.7 EUR 0.41% Market Closed
Market Cap: 72.9m EUR

Wall Street
Price Targets

OPTOMED Price Targets Summary
Optomed Oyj

Wall Street analysts forecast OPTOMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPTOMED is 4.83 EUR with a low forecast of 4.04 EUR and a high forecast of 5.46 EUR.

Lowest
Price Target
4.04 EUR
9% Upside
Average
Price Target
4.83 EUR
30% Upside
Highest
Price Target
5.46 EUR
48% Upside
Optomed Oyj Competitors:
Price Targets
DCTH
Delcath Systems Inc
134% Upside
SRTS
Sensus Healthcare Inc
103% Upside
DRIO
DarioHealth Corp
55% Upside
IRTC
iRhythm Technologies Inc
33% Upside
ANGO
AngioDynamics Inc
41% Upside
688212
Shanghai Aohua Photoelectricity Endoscope Co Ltd
26% Upside
458870
Seers Technology Co Ltd
20% Downside
100120
Vieworks Co Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
Optomed Oyj

For the last 5 years the compound annual growth rate for Optomed Oyj's revenue is 0%. The projected CAGR for the next 4 years is 27%.

0%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Optomed Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat

Net Income
Forecast

Net Income Estimate
Optomed Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPTOMED's stock price target?
Price Target
4.83 EUR

According to Wall Street analysts, the average 1-year price target for OPTOMED is 4.83 EUR with a low forecast of 4.04 EUR and a high forecast of 5.46 EUR.

What is Optomed Oyj's Revenue forecast?
Projected CAGR
27%

For the last 5 years the compound annual growth rate for Optomed Oyj's revenue is 0%. The projected CAGR for the next 4 years is 27%.

Back to Top